Patent details

Basic Information

Publication number:

EP3104886

PCT Application Number:

IB2015050919

Type:

European Patent Granted for LU

Legal Status:

Lapsed

Application number:

EP157100017

PCT Publication Number:

WO2015121783

First applicant's nationality:

Translation Language:

EPO Publication Language:

English

English Title of Invention:

IMMUNOGENIC GLYCOPROTEIN CONJUGATES

French Title of Invention:

CONJUGUÉS IMMUNOGÈNES DE GLYCOPROTÉINE

German Title of Invention:

IMMUNOGENE GLYKOPROTEINKONJUGATE

SPC Number:

Dates

Filing date:

06/02/2015

Grant date:

17/10/2018

EP Publication Date:

21/12/2016

PCT Publication Date:

20/08/2015

Claims Translation Received Date:

Translations Received Date (B1 EP Publication):

Translations Received Date (B2 EP Publication):

Translations Received Date (B3 EP Publication):

Publication date:

17/10/2018

EP B1 Publication Date:

17/10/2018

EP B2 Publication Date:

EP B3 Publication Date:

Lapsed date:

06/02/2019

Expiration date:

06/02/2035

Renunciation date:

Revocation date:

Annulment date:

Owner

From:

10/10/2018

 

 

Name:

Pfizer Inc.

Address:

235 East 42nd Street, New York, NY 10017, United States (US)

Inventor

1

Name:

PRASAD, Avvari Krishna

Address:

United States (US)

2

Name:

GU, Jianxin

Address:

United States (US)

3

Name:

YANG, Yu-ying

Address:

United States (US)

4

Name:

KIM, Jin-Hwan

Address:

United States (US)

5

Name:

KAINTHAN, Rajesh Kumar

Address:

United States (US)

Priority

Priority Number:

201461939845 P

Priority Date:

14/02/2014

Priority Country:

United States (US)

Classification

IPC classification:

A61K 39/09; A61K 47/64;

Publication

European Patent Bulletin

Issue number:

201842

Publication date:

17/10/2018

Description:

Grant (B1)

Annual Fees

Annual Fee Due Date:

Annual Fee Number:

Expected Payer:

Last Annual Fee Payment Date:

Last Annual Fee Paid Number:

Payer:

Filing date	Document type	Number of pages